TerminatedISRCTN42386710
A double blind placebo controlled discontinuation of citalopram in adolescents with major depression
Research studyAges 13–18Canada
Understand this study
Who could participate?
This study is for people with depression. Listed age limits: 13 years to 18 years. Other eligibility criteria apply.
- Listed locations
- Canada
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Terminated
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Sunnybrook and Women's College Health Sciences Centre (Canada)
- Sponsor type
- University
- Study type
- Other
- Intervention type
- Other / unclear
- Locations
- Canada
- Age range
- From 13 Years to 18 Years
- Official registry ID
- ISRCTN42386710
- Official title
Show the full official title
A double blind placebo controlled discontinuation of citalopram in adolescents with major depression
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Canada
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Sunnybrook and Women's College Health Sciences Centre (Canada), a university.
Who can participate?
This study is for people with depression. Listed age limits: 13 years to 18 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as terminated.
